NewslettersEndothelial Cell News STK32C Activated IL-6/JAK2/STAT3 Signaling and Promoted Tumor Angiogenesis By Jamie Kang - October 27, 2025 0 28 STK32C acted as a pro-angiogenic driver in colorectal cancer by activating IL-6/JAK2/STAT3 signaling via STAT3 Thr196 phosphorylation. [British Journal of Cancer] Abstract